Companies: 10,795·Total market cap: $144.5T
Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

LEXXNASDAQHealthcare● Active
$0.65
+$0.01(+1.51%)
Market Cap$13219377
P/E Ratio
52W High$1.55
52W Low$0.46
Overview

Lexaria Bioscience Corp. (LEXX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LEXX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.48lexx eps ttm · lexx earnings per shareEarnings history
PE Ratio (TTM)lexx pe ratio ttm · lexx price to earningsPE Ratio deep dive
Revenue (TTM)368000.00lexx revenue ttm · lexx annual revenueFull revenue history
Dividend YieldNo Dividenddoes lexx pay dividends · lexx dividend yieldDividend history
Shares Outstanding18.0Mlexx shares outstanding · lexx floatShares outstanding history
Next EarningsJul 13, 2026Est.lexx earnings date · lexx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$705923.00▲ +52.05% YoY
202320242025
lexaria bioscience corp. revenue · lexx revenue 2025
FY 2025Net Income-$11.9M▼ 105.37% YoY
202320242025
lexaria bioscience corp. net income · lexx profit 2025
FY 2025EPS$-0.66▼ 40.43% YoY
202320242025
lexx eps · lexaria bioscience corp. earnings per share 2025
TTM:Revenue: $368000.00Net Income: -$9.5MEPS: $-0.48View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis lexx a buy · lexx analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$1.50Low
$0.65Current
$1.50Avg Target131.98% upside
$1.50High
lexx price target · lexx 12 month forecast

Total: 2 · Buy rate: 100.0%

The LEXX analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $1.50, representing +131.98% upside from the current price of $0.65.

Stock Performance

Full History
1D+1.51%
1W+7.77%
1M+6.03%
3M-11.36%
YTD+4.80%
1Y-35.34%
5Y-90.46%

About Lexaria Bioscience Corp.

CEORichard C. Christopher
IPO DateJan 12, 2021
Employees7
CountryCA

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of act…

what is lexaria bioscience corp. · lexx stock overview · lexaria bioscience corp. company profile · who is lexaria bioscience corp. ceo · lexx NASDAQ · lexaria bioscience corp. headquarters · lexaria bioscience corp. business segments

About Stock Overview & Key Data

Lexaria Bioscience Corp. (LEXX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 12, 2021. As of the latest trading session, LEXX stock price is $0.65, with a market capitalization of $13.2M. The stock has returned -35.34% over the past 12 months and +4.80% year-to-date.

According to 2 Wall Street analysts, the consensus rating for Lexaria Bioscience Corp. stock is Buy, with an average 12-month price target of $1.50. In fiscal year 2025, Lexaria Bioscience Corp. reported revenue of $705923.00 and net income of -$11.9M. For detailed data — including Lexaria Bioscience Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Lexaria Bioscience Corp. (LEXX) stock price is $0.65. The stock is traded on NASDAQ under the ticker symbol LEXX. The 52-week range is $0.46 – $1.55.

LEXX stock priceLEXX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice